Hernandez is introducing a resolution that excoriates the anti-allergy device's manufacturer, Mylan, joining a chorus of federal lawmakers who have accused the company of price-gouging. Hernandez's resolution would urge Congress to investigate Mylan's near-monopoly on the EpiPen and would urge the federal Food and Drug Administration to reconsider denying approval of generic alternatives. “My experience with Senate Bill 1010 has made me more resolved than ever to bring transparency to these arbitrary and harmful drug price increases," he said. "In addition to the series of informational hearings on rising drug prices, I will reintroduce SB 1010 in December. The joint resolution will come up for a vote on the Senate floor Tuesday afternoon and will then head to the Assembly.

Source: Los Angeles Times August 30, 2016 15:01 UTC